Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Surgical Clinics of North America|October 30, 2025
Surgery in Low-Income and Middle-Income CountriesBrian Diskin, Mary Ann Hopkins
Surgery|May 14, 2026
Survival outcomes after neoadjuvant chemotherapy in hormone receptor-positive breast cancer patients with nodal metastases: A National Cancer Database analysisSiavash Bolourani, Brian Diskin, Nicketti Handy, et al.
Annals of Surgical Oncology|September 12, 2024
Management of Ipsilateral Breast Tumor Recurrence Following Breast Conservation Surgery for Ductal Carcinoma In Situ: A Data-Poor ZoneBrian Diskin, Varadan Sevilimedu, Monica Morrow, et al.
Annals of Surgery|May 13, 2026
Diagnosing Lymphedema After Axillary Surgery: A Prospective Comparison of Bioimpedance, Tape Measurement, and Perometer in Patients Treated with Axillary Lymph Node DissectionAndrea V Barrio, Brian Diskin, Bayley Axelrod, et al.
The Journal of Arthroplasty|June 26, 2014
Incidence of patellar clunk syndrome in fixed versus high-flex mobile bearing posterior-stabilized total knee arthroplastyNimrod Snir, Ran Schwarzkopf, Brian Diskin, et al.
International Journal of Breast Cancer|June 19, 2023
Changes in Breast Cancer Presentation during COVID-19: Experience in an Urban Academic CenterBrian Diskin, Nakisa Pourkey, Freya Schnabel, et al.
JAMA Network Open|February 26, 2025
Trends in Guideline-Concordant Care for Inflammatory Breast CancerAudree Tadros, Brian Diskin, Varadan Sevilimedu, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2025
Once-Daily Postmastectomy Radiation Therapy Confers Excellent Locoregional Control for Inflammatory Breast CancerKate R Pawloski, Amy Xu, Brian Diskin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 12, 2025
Uncovering the Red Flags: A Cross-Sectional Retrospective Case-Control Study on Predictors of Early Onset Colorectal Cancer in a Multi-State Community Health SystemSaul A Castro, Robyn A Husa, Ann Vita, et al.
Cancer Discovery|July 27, 2018
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer ModelsCarmine Fedele, Hao Ran, Brian Diskin, et al.
Pageof 3